Contact
QR code for the current URL

Story Box-ID: 141436

Hummingbird Diagnostics GmbH Im Neuenheimer Feld 519 69120 Heidelberg, Germany http://www.hummingbird-diagnostics.com
Contact Ms Wendy Lau +1 212-845-4271
Company logo of Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH

febit Appoints David Mahoney Director of Global Intellectual Property and U.S. Legal Affairs

(PresseBox) (Heidelberg, Germany, and Medford, Mass.,, )
febit holding gmbh today announced the addition of David Mahoney to the newly created position of director of global intellectual property and U.S. legal affairs.

As director of global intellectual property and U.S. legal affairs, Mahoney will be based in febit’s U.S. offices and will be responsible for managing U.S. legal matters and the intellectual property portfolio of the febit group. Mahoney brings to febit experience in international intellectual property management, encompassing corporate litigation matters and licensing issues. Prior to joining febit, Mahoney was U.S. director of legal affairs for Sygnis Pharma AG. He is also registered to practice before the U.S. Patent and Trademark Office.

"The addition of David Mahoney to febit is an important step as we continue with the development of highly innovative technologies for genomic research," said Cord F. Staehler, president and CEO of febit holding gmbh. "febit currently holds more than 20 patents and patent applications for bioanalytics and the manufacture of synthetic genes on biochips, and we plan to continue with significant advances in this area."

"Safeguarding intellectual properties and rights of use by potent IP strategies and comprehensive patent protection is vital in the dynamic and competitive biotechnology market," said Mahoney. "I am pleased to join febit in the ongoing development of highly innovative technologies."For more information please visit www.febit.eu.

Hummingbird Diagnostics GmbH

Developing innovative and creative technologies for genomic research is the corporate mission of the febit group, a German-American biotech company. Geniom is a technological and service platform successfully used in basic and applied research of renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes providing superior time and cost efficiency combined with an unsurpassed spectrum of applications (Geno-, SNP- and Pathogentyping, Enzyme-on-Chip, miRNA-Profiling and many more). With the unique Geniom Technology febit now enters the high-potential market of synthetic biology with a novel method for production of synthetic genes. Using both, highly integrated automation and extensive customizability, febit meets essential needs of current biomedical research.

www.febit.com

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.